The U.S. FDA moves to remove black box warnings from hormone replacement therapy products used for menopause. Read more here.
The decision aims to improve access to HRT by removing warnings about cardiovascular disease, breast cancer, and probable dementia. HHS has initiated removal of black box warnings on hormone ...
( NewsNation) — Health Secretary Robert F. Kennedy Jr. announced Monday that the U.S. Food and Drug Administration will begin ...
The US Food and Drug Administration intends to remove most black box warnings from products containing estrogen and progestogen. The decision, announced Monday, is part of a campaign to promote wider ...